Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.
‘Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin‘
In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.
Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.
I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.
Many thanks to all co-authors and collaborators who made this work possible.”
Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Ferritin Levels and Transferrin Saturation, Reflecting Rapid Iron Accumulation and Reduced Iron Utilization
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination
-
Jun 3, 2026, 16:04Gurpreet Kaur Sagoo: Diagnosing PNH in Aplastic Anaemia – Looking Beyond the Marrow
-
Jun 3, 2026, 16:04Jan Hartmann: An Illustrated Review Of Viscoelastic Testing Reaches 100 Citations
-
Jun 3, 2026, 16:01Andrea Losito: For Stroke Survivors, Having a Community that Understands and Triumphs Can Make a Lasting Impact
-
Jun 3, 2026, 15:54Karen Phillips: Surprisingly High Cumulative Clinical Bleeding Events In Post-Ablation AF Patients
-
Jun 3, 2026, 15:47Michael Makris: How Haemophilia Care Is Delivered in China